Erik Mittra

Publications

• Combined 18F-fluoride and 18F-FDG PET/CT scanning for evaluation of malignancy: results of an international multicenter trial. Iagaru A, Mittra E, Mosci C, Dick DW, Sathekge M, Prakash V, Iyer V, Lapa P, Isidoro J, de Lima JM, Gambhir SS. J Nucl Med. 2013; 54 (2): 176-83
• Pilot Prospective Evaluation of 99mTc-MDP Scintigraphy, 18F NaF PET/CT, 18F FDG PET/CT and Whole-Body MRI for Detection of Skeletal Metastases. Iagaru A, Young P, Mittra E, Dick DW, Herfkens R, Gambhir SS. Clin Nucl Med. 2013
• A brain tumor molecular imaging strategy using a new triple-modality MRI-photoacoustic-Raman nanoparticle. Kircher MF, de la Zerda A, Jokerst JV, Zavaleta CL, Kempen PJ, Mittra E, Pitter K, Huang R, Campos C, Habte F, Sinclair R, Brennan CW, Mellinghoff IK, Holland EC, Gambhir SS. Nat Med. 2012; 18 (5): 829-34
• Exploratory clinical trial of (4S)-4-(3-[18F]fluoropropyl)-L-glutamate for imaging xC- transporter using positron emission tomography in patients with non-small cell lung or breast cancer. Baek S, Choi CM, Ahn SH, Lee JW, Gong G, Ryu JS, Oh SJ, Bacher-Stier C, Fels L, Koglin N, Hultsch C, Schatz CA, Dinkelborg LM, Mittra ES, Gambhir SS, Moon DH. Clin Cancer Res. 2012; 18 (19): 5427-37
• First experience with clinical-grade ([18F]FPP(RGD₂): an automated multi-step radiosynthesis for clinical PET studies. Chin FT, Shen B, Liu S, Berganos RA, Chang E, Mittra E, Chen X, Gambhir SS. Mol Imaging Biol. 2012; 14 (1): 88-95
• Prospective comparison of combined 18F-FDG and 18F-NaF PET/CT vs. 18F-FDG PET/CT imaging for detection of malignancy. Lin FI, Rao JE, Mittra ES, Nallapareddy K, Chengapa A, Dick DW, Gambhir SS, Iagaru A. Eur J Nucl Med Mol Imaging. 2012; 39 (2): 262-70
• Prospective evaluation of (99m)Tc MDP scintigraphy, (18)F NaF PET/CT, and (18)F FDG PET/CT for detection of skeletal metastases. Iagaru A, Mittra E, Dick DW, Gambhir SS. Mol Imaging Biol. 2012; 14 (2): 252-9
• Case 166: Metastatic left pulmonary artery sarcoma. Mittra ES, Iagaru AH, Leung AN. Radiology. 2011; 258 (2): 645-8
• FDG-PET/CT in cancers of the head and neck: what is the definition of whole body scanning? Iagaru A, Mittra ES, Gambhir SS. Mol Imaging Biol. 2011; 13 (2): 362-7
• Pilot pharmacokinetic and dosimetric studies of (18)F-FPPRGD2: a PET radiopharmaceutical agent for imaging α(v)β(3) integrin levels. Mittra ES, Goris ML, Iagaru AH, Kardan A, Burton L, Berganos R, Chang E, Liu S, Shen B, Chin FT, Chen X, Gambhir SS. Radiology. 2011; 260 (1): 182-91
• 131I-Tositumomab (Bexxar) vs. 90Y-Ibritumomab (Zevalin) therapy of low-grade refractory/relapsed non-Hodgkin lymphoma. Iagaru A, Mittra ES, Ganjoo K, Knox SJ, Goris ML. Mol Imaging Biol. 2010; 12 (2): 198-203
• Case 166. Mittra ES, Iagaru AH, Leung AN. Radiology. 2010; 257 (1): 288-9
• Combined 18F-FDG and Fluoride Approach in PET/CT Imaging: Is There a Clinical Future? Iagaru A, Mittra E, Goris ML, Gambhir SS. J Nucl Med. 2009
• Cutaneous graft-versus-host disease on Tc-99m leukocyte scintigraphy. Mittra E, McDougall IR. Clin Nucl Med. 2009; 34 (12): 894-5
• Efficacy of 18F-FDG PET/CT in the evaluation of patients with recurrent cervical carcinoma. Mittra E, El-Maghraby T, Rodriguez CA, Quon A, McDougall IR, Gambhir SS, Iagaru A. Eur J Nucl Med Mol Imaging. 2009; 36 (12): 1952-9
• Novel strategy for a cocktail 18F-fluoride and 18F-FDG PET/CT scan for evaluation of malignancy: results of the pilot-phase study. Iagaru A, Mittra E, Yaghoubi SS, Dick DW, Quon A, Goris ML, Gambhir SS. J Nucl Med. 2009; 50 (4): 501-5
• Positron emission tomography/computed tomography: the current technology and applications. Mittra E, Quon A. Radiol Clin North Am. 2009; 47 (1): 147-60
• 18F-FDG PET/CT evaluation of patients with ovarian carcinoma. Iagaru AH, Mittra ES, McDougall IR, Quon A, Gambhir SS. Nucl Med Commun. 2008; 29 (12): 1046-51
• Evaluation of trabecular mechanical and microstructural properties in human calcaneal bone of advanced age using mechanical testing, microCT, and DXA. Mittra E, Rubin C, Gruber B, Qin YX. J Biomech. 2008; 41 (2): 368-75
• Uncommon causes of thyrotoxicosis. Mittra ES, Niederkohr RD, Rodriguez C, El-Maghraby T, McDougall IR. J Nucl Med. 2008; 49 (2): 265-78
• A case of three synchronous primary tumors demonstrated by F-18 FDG PET. Mittra E, Vasanawala M, Niederkohr R, Rodriguez C, Segall G. Clin Nucl Med. 2007; 32 (8): 666-7
• Comparative morphometrics of the primate apical tuft. Mittra ES, Smith HF, Lemelin P, Jungers WL. Am J Phys Anthropol. 2007; 134 (4): 449-59
• Concurrent metabolic and osseous metastatic disease on a Tc99m-MDP bone scan. Mittra E, Segall G. Eur J Nucl Med Mol Imaging. 2007; 34 (12): 2150
• Recurrent silent thyroiditis: a report of four patients and review of the literature. Mittra ES, McDougall IR. Thyroid. 2007; 17 (7): 671-5
• Determination of ultrasound phase velocity in trabecular bone using time dependent phase tracking technique. Lin W, Mittra E, Qin YX. J Biomech Eng. 2006; 128 (1): 24-9
• The effects of embedding material, loading rate and magnitude, and penetration depth in nanoindentation of trabecular bone. Mittra E, Akella S, Qin YX. J Biomed Mater Res A. 2006; 79 (1): 86-93
• Interrelationship of trabecular mechanical and microstructural properties in sheep trabecular bone. Mittra E, Rubin C, Qin YX. J Biomech. 2005; 38 (6): 1229-37
• Quantity and quality of trabecular bone in the femur are enhanced by a strongly anabolic, noninvasive mechanical intervention. Rubin C, Turner AS, Müller R, Mittra E, McLeod K, Lin W, Qin YX. J Bone Miner Res. 2002; 17 (2): 349-57
• Lack of hand preference in wild Hanuman langurs (Presbytis entellus). Mittra ES, Fuentes A, McGrew WC. Am J Phys Anthropol. 1997; 103 (4): 455-61